Literature DB >> 28559392

Renal Dysfunction Induced by Kidney-Specific Gene Deletion of Hsd11b2 as a Primary Cause of Salt-Dependent Hypertension.

Kohei Ueda1, Mitsuhiro Nishimoto2, Daigoro Hirohama2, Nobuhiro Ayuzawa2, Wakako Kawarazaki2, Atsushi Watanabe2, Tatsuo Shimosawa2, Johannes Loffing2, Ming-Zhi Zhang2, Takeshi Marumo2, Toshiro Fujita1.   

Abstract

Genome-wide analysis of renal sodium-transporting system has identified specific variations of Mendelian hypertensive disorders, including HSD11B2 gene variants in apparent mineralocorticoid excess. However, these genetic variations in extrarenal tissue can be involved in developing hypertension, as demonstrated in former studies using global and brain-specific Hsd11b2 knockout rodents. To re-examine the importance of renal dysfunction on developing hypertension, we generated kidney-specific Hsd11b2 knockout mice. The knockout mice exhibited systemic hypertension, which was abolished by reducing salt intake, suggesting its salt-dependency. In addition, we detected an increase in renal membrane expressions of cleaved epithelial sodium channel-α and T53-phosphorylated Na+-Cl- cotransporter in the knockout mice. Acute intraperitoneal administration of amiloride-induced natriuresis and increased urinary sodium/potassium ratio more in the knockout mice compared with those in the wild-type control mice. Chronic administration of amiloride and high-KCl diet significantly decreased mean blood pressure in the knockout mice, which was accompanied with the correction of hypokalemia and the resultant decrease in Na+-Cl- cotransporter phosphorylation. Accordingly, a Na+-Cl- cotransporter blocker hydrochlorothiazide significantly decreased mean blood pressure in the knockout mice. Chronic administration of mineralocorticoid receptor antagonist spironolactone significantly decreased mean blood pressure of the knockout mice along with downregulation of cleaved epithelial sodium channel-α and phosphorylated Na+-Cl- cotransporter expression in the knockout kidney. Our data suggest that kidney-specific deficiency of 11β-HSD2 leads to salt-dependent hypertension, which is attributed to mineralocorticoid receptor-epithelial sodium channel-Na+-Cl- cotransporter activation in the kidney, and provides evidence that renal dysfunction is essential for developing the phenotype of apparent mineralocorticoid excess.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  apparent mineralocorticoid excess syndrome; blood pressure; hypertension; hypokalemia; mineralocorticoid receptor

Mesh:

Substances:

Year:  2017        PMID: 28559392     DOI: 10.1161/HYPERTENSIONAHA.116.08966

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

1.  Two Mineralocorticoid Receptor-Mediated Mechanisms of Pendrin Activation in Distal Nephrons.

Authors:  Nobuhiro Ayuzawa; Mitsuhiro Nishimoto; Kohei Ueda; Daigoro Hirohama; Wakako Kawarazaki; Tatsuo Shimosawa; Takeshi Marumo; Toshiro Fujita
Journal:  J Am Soc Nephrol       Date:  2020-02-07       Impact factor: 10.121

Review 2.  Animal Models of Hypertension: A Scientific Statement From the American Heart Association.

Authors:  Lilach O Lerman; Theodore W Kurtz; Rhian M Touyz; David H Ellison; Alejandro R Chade; Steven D Crowley; David L Mattson; John J Mullins; Jeffrey Osborn; Alfonso Eirin; Jane F Reckelhoff; Costantino Iadecola; Thomas M Coffman
Journal:  Hypertension       Date:  2019-06       Impact factor: 10.190

3.  Whole-Genome Sequencing of 100 Genomes Identifies a Distinctive Genetic Susceptibility Profile of Qatari Patients with Hypertension.

Authors:  Alsamman M Alsamman; Hakeem Almabrazi; Hatem Zayed
Journal:  J Pers Med       Date:  2022-04-29

Review 4.  The interplay of renal potassium and sodium handling in blood pressure regulation: critical role of the WNK-SPAK-NCC pathway.

Authors:  Aihua Wu; Martin Wolley; Michael Stowasser
Journal:  J Hum Hypertens       Date:  2019-02-05       Impact factor: 3.012

5.  Abnormal neonatal sodium handling in skin precedes hypertension in the SAME rat.

Authors:  Linda Mullins; Jessica Ivy; Mairi Ward; Olav Tenstad; Helge Wiig; Kento Kitada; Jon Manning; Natalia Rakova; Dominik Muller; John Mullins
Journal:  Pflugers Arch       Date:  2021-05-24       Impact factor: 3.657

Review 6.  Impact of Nutritional Epigenetics in Essential Hypertension: Targeting microRNAs in the Gut-Liver Axis.

Authors:  Johnathan Kawika Cooper; Rochell Issa; Pratyush Pavan Devarasetty; Rachel M Golonka; Veda Gokula; Joshua Busken; Jasenka Zubcevic; Jennifer Hill; Matam Vijay-Kumar; Bindu Menon; Bina Joe
Journal:  Curr Hypertens Rep       Date:  2021-05-07       Impact factor: 5.369

7.  Decreased 11β-Hydroxysteroid Dehydrogenase Type 2 Expression in the Kidney May Contribute to Nicotine/Smoking-Induced Blood Pressure Elevation in Mice.

Authors:  Ying Wang; Jian Wang; Rong Yang; Piwen Wang; Rene Porche; Samuel Kim; Kabirullah Lutfy; Limei Liu; Theodore C Friedman; Meisheng Jiang; Yanjun Liu
Journal:  Hypertension       Date:  2021-04-05       Impact factor: 9.897

Review 8.  11β-Hydroxysteroid Dehydrogenases and Hypertension in the Metabolic Syndrome.

Authors:  Matthew A Bailey
Journal:  Curr Hypertens Rep       Date:  2017-11-14       Impact factor: 5.369

Review 9.  Genetic Modifications to Alter Blood Pressure Level.

Authors:  Hiroki Ohara; Toru Nabika
Journal:  Biomedicines       Date:  2022-08-01

Review 10.  The Mineralocorticoid Receptor in Salt-Sensitive Hypertension and Renal Injury.

Authors:  Nobuhiro Ayuzawa; Toshiro Fujita
Journal:  J Am Soc Nephrol       Date:  2021-01-04       Impact factor: 10.121

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.